A comprehensive view of Boston Scientific Corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Boston Scientific's Farapulse PulseSelect Pulsed-Field Ablation system gains foothold in the US PFA system market; J&J remains top player in electrophysiology devices market with 54% market share
Published:
April 19, 2024
by MarketLine
|
Boston Scientific recalls Obsidio Conformable Embolic blood flow blocking agent due to safety issues; the product is used to block blood supply to tumors and to treat bleeding in patients
Published:
April 18, 2024
by MedTech Dive
|
US Patent Issued to Boston Scientific Neuromodulation on April 16 for "Neuromodulation for neuroinflammation treatments with parameters controlled using biomarkers" (Texas, California Inventors)
Published:
April 17, 2024
by U.S. Fed News
|
US Patent Issued to Boston Scientific Neuromodulation on April 16 for "Sensor-based pain management systems and methods" (Minnesota, California Inventors)
Published:
April 17, 2024
by U.S. Fed News
|
US Patent Issued to Boston Scientific Neuromodulation on April 16 for "Collection of clinical data for graphical representation and analysis" (Ohio, California Inventors)
Published:
April 17, 2024
by U.S. Fed News
|
Ask us about our Tissue & Hygiene market view